Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Revive Therapeutics Ltd
Bullboard Posts
User Avatar Image
(198)
•••
Post by daveholtonon Feb 16, 2020 4:31pm
92 Views
Post# 30697842

More Revive BS uncovered by CIFC Capital...

More Revive BS uncovered by CIFC Capital...This is pure comedy at this point...

https://twitter.com/CIFCcapital/status/1229092924681420800

After our thread, many people pointed us towards other information on the company. Here's yet another ridiculous finding: a $4.5M acquisition of "AI data software business" Must be cutting edge AI and tech, surely? Well, we dug in to "Greeninsightz"..

Here's "Greeninsightz" pitch: GreenInsightz continuously retrieves and analyzes Twitter using a powerful analytics engine designed for social media. Unlike in a regular timeline, the most engaged accounts are ranked higher, the most shared links are immediately accessible

irst of all, what does a "cannabis life sciences" co need "AI" for? Second of all, how is "Greeninsightz" doing anything remotely cannabis related? This is a glorified Twitter bot program, rolled up for $4.5M in stock. How does $RVV $RVV.C justify this to shareholders?

The cherry on top with this one is, when you go to "Greeninsightz" website and hit "Products" to try to figure out how they, you know, like, make money... Here's what you will find: An error page. $4.5M and they don't have a product page?

So it begs the question: what exactly was $RVV $RVV.C buying here? A "organized Twitter timeline" ? Where is the product? Where are the clients? What about this tech actually makes it worth .04c let alone $4.5M dollars? We have our guesses but will leave there.. for now /end

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities